BBNX
Beta Bionics·NASDAQ
--
--(--)
--
--(--)
5.13 / 10
Netural
Fund flow metrics score 7.75/10, revealing robust fund flow characteristics. Beneficial overall, block, Small, and Extra-large trends are challenged by problematic Medium and Large signals, indicating positive capital movement. Analyst sentiment reflects predominantly positive analyst sentiment with moderate confidence. The rating profile includes Strong Buy(66.7%), Neutral(33.3%) from 3 analytical reports, supported by 2.52 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-04
InstitutionStifel
Times predicted3
Historical Win Rate66.7%
What is the analyst consensus for BBNX?
- BBNX holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.13/10 (Netural).
